Scale with AI Qualifyze has a growing client base of 1,500+ pharma users and a clear shift from audits to AI-driven insights and predictive compliance. Opportunity: position expanded analytics and proactive supplier risk forecasting as a premium service for broader Life Sciences use cases and larger enterprises seeking end-to-end risk management.

US Market Entry Recent funding and leadership additions coupled with stated plans to extend operations into the US indicate a focus on geographic expansion. Opportunity: tailor a US-first go-to-market package highlighting regulatory alignment, local partner ecosystems, and scalable deployment to win US-based pharma and biotech customers.

Compliance as Service Cloud-based platform delivering real-time access to supplier compliance data positions Qualifyze as a continuous risk-monitoring partner rather than a point-in-time auditor. Opportunity: upsell ongoing monitoring, automated remediation workflows, and integration with existing supplier management suites for ongoing value.

Strategic Partnerships Recent multi-party ESG audits and a Partner announcement signal collaboration opportunities beyond audits. Opportunity: pursue co-sell with ESG-focused evaluators, contract manufacturers, and pharmaceuticals seeking integrated compliance and ESG risk visibility.

Executive Engagement Board-level appointments and high-profile funding rounds show momentum and credibility with investors and customers. Opportunity: target senior procurement, supplier risk, and CIO/CTO executives with tailored business cases emphasizing cost-of-risk reduction, efficiency gains, and data-driven decision support.